{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:32:20Z","timestamp":1788816740497,"version":"build-2803163510"},"reference-count":134,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation","award":["075-15-2025-013"],"award-info":[{"award-number":["075-15-2025-013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Tuberculosis remains a serious infectious disease that causes over 1.3 million deaths annually. Following the COVID-19 pandemic, the global incidence of tuberculosis has increased to 10.8 million cases. Pregnant women represent a particularly vulnerable population requiring tailored approaches to the prevention, diagnosis, and treatment of tuberculosis. SARS-CoV-2 infection may have impacted existing clinical protocols. Implementing updated methods of tuberculosis prevention, diagnosis, and treatment in pregnant women could help reduce adverse maternal and fetal outcomes. The aim of this review was to explore potential modifications in tuberculosis management among pregnant women in the post-COVID-19 era, including co-infection with SARS-CoV-2. Methods: A review was conducted, incorporating a systematic literature search across major international databases, including Medline, PubMed, Web of Science, Scopus, and Google Scholar. The search covered publications released between December 2019 and September 2024 and used targeted keywords such as \u201cCOVID-19\u201d OR \u201cSARS-CoV-2\u201d, \u201ctuberculosis\u201d OR \u201cTB\u201d OR \u201clatent tuberculosis infection\u201d OR \u201cpulmonary tuberculosis\u201d, and \u201cpregnancy\u201d OR \u201cpregnant women\u201d. Results: Pregnant women living with HIV are at increased risk of developing tuberculosis, which can negatively affect both maternal and perinatal outcomes. Screening for tuberculosis is recommended for all HIV-positive pregnant women, even in the absence of clinical symptoms. Notably, immunological testing before and during pregnancy facilitates the timely and safe detection of tuberculosis infection, enabling preventive and therapeutic interventions during any stage of gestation and the early postpartum period, for the benefit of both mother and child. Drug\u2013drug interactions play a significant role in tuberculosis management, both among anti-tuberculosis agents and with medications for comorbid conditions. Current knowledge of the pharmacokinetics and pharmacodynamics of antituberculosis agents, coupled with therapeutic drug monitoring, supports the development of individualized and effective treatment regimens, which are particularly critical for pregnant patients. Recommendations for managing tuberculosis in pregnant women after COVID-19 infection include measuring D-dimer levels, performing echocardiography, and consulting cardiologists to prevent treatment-related complications. Conclusions: Pregnant women represent a distinct subgroup of tuberculosis patients requiring individualized management. Changes observed in tuberculosis progression and treatment responses in pregnant women before and after SARS-CoV-2 infection should inform therapeutic choices, especially in cases of drug-resistant tuberculosis treated with bedaquiline. COVID-19 has been associated with increased cardiovascular risk, which may heighten the likelihood of adverse drug reactions in this population, especially given the limited therapeutic options. Further research is required to assess the long-term outcomes of latent tuberculosis infection in pregnant women and to evaluate the safety and efficacy of novel regimens for drug-resistant TB during pregnancy.<\/jats:p>","DOI":"10.3390\/jcm14165681","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T14:32:36Z","timestamp":1754922756000},"page":"5681","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tuberculosis in Pregnant Women After COVID-19: Features of Prevention, Diagnosis, and Treatment (Narrative Review)"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-6986","authenticated-orcid":false,"given":"Anna","family":"Starshinova","sequence":"first","affiliation":[{"name":"Department of Mathematics and Computer Science, St-Petersburg State University, St. Petersburg 199034, Russia"},{"name":"Almazov National Medical Research Centre, St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Belyaeva","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Computer Science, St-Petersburg State University, St. Petersburg 199034, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-3191","authenticated-orcid":false,"given":"Olga","family":"Irtyuga","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2273-8300","authenticated-orcid":false,"given":"Giunai","family":"Sefiyeva","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubov","family":"Mitrofanova","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-8403","authenticated-orcid":false,"given":"Igor","family":"Makarov","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Makarova","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kulpina","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Computer Science, St-Petersburg State University, St. Petersburg 199034, Russia"},{"name":"Almazov National Medical Research Centre, St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-4467","authenticated-orcid":false,"given":"Dmitry","family":"Kudlay","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University, Moscow 119991, Russia"},{"name":"Institute of Immunology FMBA of Russia, Moscow 115522, Russia"},{"name":"Department of Pharmacognosy and Industrial Pharmacy, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024). Global Tuberculosis Report 2024, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Harding, E. (2020). WHO Global Progress Report on Tuberculosis Elimination. Lancet Respir. Med., 8.","DOI":"10.1016\/S2213-2600(19)30418-7"},{"key":"ref_3","unstructured":"World Health Organization and the European Centre for Disease Prevention and Control (2023). Tuberculosis Surveillance and Monitoring in Europe 2023: 2021 Data. 3, World Health Organization and the European Centre for Disease Prevention and Control."},{"key":"ref_4","unstructured":"WHO Consolidated Guidelines on Tuberculosis (2022). Module 4: Treatment\u2014Drug-Susceptible Tuberculosis Treatment, World Health Organization."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.21292\/2075-1230-2018-96-7-62-63","article-title":"Impact of tuberculosis on the course of pregnancy, delivery and perinatal outcomes","volume":"96","author":"Nesterenko","year":"2018","journal-title":"Tuberc. Lung Dis."},{"key":"ref_6","unstructured":"Mitnick, C., Khan, U., and Guglielmetti, L. (2023, January 15\u201318). SP01 Innovation to guide practice in MDR\/RR-TB treatment: Efficacy and safety results of the end TB trial. Proceedings of the Union World Conference on Lung Health, Paris, France."},{"key":"ref_7","unstructured":"WHO Consolidated Guidelines on Tuberculosis (2022). Module 5: Management of Tuberculosis in Children and Adolescents, World Health Organization."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1111\/bcp.15380","article-title":"Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosis","volume":"88","author":"Court","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1016\/S2214-109X(14)70330-4","article-title":"Tuberculosis in pregnancy: An estimate of the global burden of disease","volume":"2","author":"Sugarman","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Jonsson, J., K\u00fchlmann-Berenzon, S., Berggren, I., and Bruchfeld, J. (2020). Increased risk of active tuberculosis during pregnancy and postpartum: A register-based cohort study in Sweden. Eur. Respir. J., 55.","DOI":"10.1183\/13993003.01886-2019"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bothamley, G.H., Ehlers, C., Salonka, I., Skrahina, A., Orcau, A., Codecasa, L.R., Ferrarese, M., Pesut, D., Solovic, I., and Dudnyk, A. (2016). Pregnancy in patients with tuberculosis: A TBNET cross-sectional survey. BMC Pregnancy Childbirth, 16.","DOI":"10.1186\/s12884-016-1096-4"},{"key":"ref_12","first-page":"130","article-title":"Untreated Prior Pulmonary Tuberculosis Adversely Affects Pregnancy Outcomes in Infertile Women Undergoing in vitro Fertilization and Embryo Transfer: A Large Retrospective Cohort Study","volume":"34","author":"Gai","year":"2021","journal-title":"Biomed. Enviorn. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/1471-0528.16573","article-title":"Multidrug-resistant tuberculosis during pregnancy and adverse birth outcomes: A systematic review and meta-analysis","volume":"128","author":"Alene","year":"2021","journal-title":"Int. J. Obstet. Gynaecol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijgo.13588","article-title":"Clinical presentations, pregnancy complications, and maternal outcomes in pregnant women with COVID-19 and tuberculosis: A retrospective cohort study","volume":"153","author":"Gajbhiye","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_15","first-page":"127","article-title":"COVID-19 and tuberculosis co-infection in pregnancy\u2014A case series and review","volume":"25","author":"Modi","year":"2022","journal-title":"J. Mother Child."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bpobgyn.2022.07.006","article-title":"Tuberculosis in pregnancy","volume":"85 Pt A","author":"Hui","year":"2022","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.12740\/PP\/152125","article-title":"Infections and mental diseases: From tuberculosis to COVID-19","volume":"56","author":"Rybakowski","year":"2022","journal-title":"Psychiatr. Pol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kudlay, D., Kofiadi, I., and Khaitov, M. (2022). Peculiarities of the T Cell Immune Response in COVID-19. Vaccines, 10.","DOI":"10.3390\/vaccines10020242"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Savchenko, A.A., Tikhonova, E., Kudryavtsev, I., Kudlay, D., Korsunsky, I., Beleniuk, V., and Borisov, A. (2022). TREC\/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease. Viruses, 14.","DOI":"10.3390\/v14030646"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Starshinova, A.A., Kudryavtsev, I., Malkova, A., Zinchenko, U., Karev, V., Kudlay, D., Glushkova, A., Starshinova, A.Y., Dominguez, J., and Villar-Hern\u00e1ndez, R. (2022). Molecular and Cellular Mechanisms of M. tuberculosis and SARS-CoV-2 Infections\u2014Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042235"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ehjci\/jeaa212","article-title":"Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19","volume":"22","author":"Theocharis","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Makarov, I., Mayrina, S., Makarova, T., Karonova, T., Starshinova, A., Kudlay, D., and Mitrofanova, L. (2023). Morphological Changes in the Myocardium of Patients with Post-Acute Coronavirus Syndrome: A Study of Endomyocardial Biopsies. Diagnostics, 13.","DOI":"10.3390\/diagnostics13132212"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mitrofanova, L.B., Makarov, I.A., Gorshkov, A.N., Runov, A.L., Vonsky, M.S., Pisareva, M.M., Komissarov, A.B., Makarova, T.A., Li, Q., and Karonova, T.L. (2023). Comparative Study of the Myocardium of Patients from Four COVID-19 Waves. Diagnostics, 13.","DOI":"10.3390\/diagnostics13091645"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2022.12.020","article-title":"Impact of asymptomatic and mild COVID-19 infection on fetal growth during pregnancy","volume":"281","author":"Narang","year":"2023","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.ijid.2021.12.110","article-title":"Asymptomatic forms of COVID-19 in pregnant women: Long-term consequences","volume":"116","author":"Abuova","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Esakandari, H., Nabi-Afjadi, M., Fakkari-Afjadi, J., Farahmandian, N., Miresmaeili, S.M., and Bahreini, E. (2020). A comprehensive review of COVID-19 characteristics. Biol. Proced. Online, 22.","DOI":"10.1186\/s12575-020-00128-2"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacbts.2022.09.001","article-title":"Human Cardiac Pericytes Are Susceptible to SARS-CoV-2 Infection","volume":"8","author":"Brumback","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.01.002","article-title":"Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia","volume":"282","author":"Mojiri","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.22625\/2072-6732-2021-13-2-38-43","article-title":"Novel coronavirus infection (COVID-19) in tuberculosis patients in St. Petersburg","volume":"13","author":"Malashenkov","year":"2021","journal-title":"J. Infectol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jacc.2020.11.031","article-title":"Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week","volume":"77","author":"Kawakami","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1086\/315818","article-title":"Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy","volume":"182","author":"Bourlet","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mitrofanova, L., Makarov, I., Gorshkov, A., Vorobeva, O., Simonenko, M., Starshinova, A., Kudlay, D., and Karonova, T. (2023). New Scenarios in Heart Transplantation and Persistency of SARS-CoV-2 (Case Report). Life, 13.","DOI":"10.20944\/preprints202306.0889.v1"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gao, Y.-P., Zhou, W., Huang, P.-N., Liu, H.-Y., Bi, X.-J., Zhu, Y., Sun, J., Tang, Q.-Y., Li, L., and Zhang, J. (2022). Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery. Front. Med., 9.","DOI":"10.3389\/fmed.2022.809033"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Cruz-Lemini, M., Ferriols Perez, E., de la Cruz Conty, M.L., Ca\u00f1o Aguilar, A., Encinas Pardilla, M.B., Prats Rodr\u00edguez, P., Muner Hernando, M., Forcen Acebal, L., Pintado Recarte, P., and Medina Mallen, M.d.C. (2021). Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women. Viruses, 13.","DOI":"10.3390\/v13010112"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_150_20","article-title":"Cardiovascular Manifes-tations of COVID-19","volume":"21","author":"Altamimi","year":"2020","journal-title":"Heart Views"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Nascimento, A.C.M., Avvad-Portari, E., Meuser-Batista, M., Conde, T.C., de S\u00e1, R.A.M., Salomao, N., Rabelo, K., Ciasca, E.S., Brendolin, M.d.O., and Vasconcelos, Z. (2024). Histopathological and clinical analysis of COVID-19-infected placentas. Surg. Exp. Pathol., 7.","DOI":"10.1186\/s42047-024-00146-4"},{"key":"ref_38","first-page":"167","article-title":"Villitis of Unknown Etiology in the Placenta of a Pregnancy Complicated by COVID-19. Villitis of Unknown Etiology in the Placenta of a Pregnancy Complicated by COVID-19","volume":"37","author":"Ozer","year":"2021","journal-title":"Turk. Patoloji. Derg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4274\/tjod.galenos.2021.74829","article-title":"Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19","volume":"18","author":"Bahrami","year":"2021","journal-title":"Turk. J. Obstet. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18565\/aig.2022.260","article-title":"Association between new coronavirus infection and fetal growth restriction","volume":"2","author":"Lipatov","year":"2023","journal-title":"Akusherstvo I Ginekol.\/Obstet. Gynecol."},{"key":"ref_41","first-page":"314","article-title":"Morfofunktsional\u2019nye osobennosti platsenty pri tuberkulyoze vo vremya beremennosti [Morphofunctional features of the placenta in pregnant women with tuberculosis]","volume":"25","author":"Valdoshova","year":"2023","journal-title":"Vestn. Avitsenny [Avicenna Bull.]"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/hrt.68.12.540","article-title":"Adaptation of the maternal heart in pregnancy","volume":"68","author":"Hunter","year":"1992","journal-title":"Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.redar.2020.05.007","article-title":"SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection","volume":"7","author":"Llau","year":"2020","journal-title":"Rev. Esp. Anestesiol. Reanim. (Engl. Ed.)"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/S2352-3026(21)00105-8","article-title":"COVID-19-associated coagulopathy and antithrombotic agents\u2014Lessons after 1 year","volume":"8","author":"Leentjens","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mir, N., D\u2019Amico, A., Dasher, J., Tolwani, A., and Valentine, V. (2021). Understanding the andromeda strain\u2014The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness. Blood Rev., 45.","DOI":"10.1016\/j.blre.2020.100731"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Knight, M., Bunch, K., Vousden, N., Morris, E., Simpson, N., Gale, C., O\u2019bRien, P., Quigley, M., Brocklehurst, P., and Kurinczuk, J.J. (2020). Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: National population based cohort study. Br. Med. J., 369.","DOI":"10.1101\/2020.05.08.20089268"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Pierce-Williams, R.A., Burd, J., Felder, L., Khoury, R., Bernstein, P.S., Avila, K., Penfield, C.A., Roman, A.S., DeBolt, C.A., and Stone, J.L. (2020). Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: A United States cohort study. Am. J. Obstet. Gynecol. MFM, 2.","DOI":"10.1016\/j.ajogmf.2020.100134"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zahid, S., Agrawal, A., Rai, D., Khan, M.Z., and Michos, E.D. (2023). Cardiovascular complications associated with COVID-19 during delivery hospitalizations in pandemic year 2020. JACC Adv., 2.","DOI":"10.1016\/j.jacadv.2023.100386"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/cvr\/cvab298","article-title":"Cardiovascular disease and COVID-19: A consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on thrombosis and the association for acute CardioVascular care (ACVC), in collaboration with the European heart rhythm association (EHRA)","volume":"117","author":"Cenko","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: The ACTIV-4B randomized clinical trial","volume":"326","author":"Connors","year":"2021","journal-title":"J. Am. Med. Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19","volume":"76","author":"Piazza","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamainternmed.2021.0488","article-title":"Incidence of 30-day venous thromboembolism in adults tested for SARS-CoV-2 infection in an integrated health care system in Northern California","volume":"181","author":"Roubinian","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.thromres.2024.02.021","article-title":"Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19","volume":"237","author":"Bikdeli","year":"2024","journal-title":"Thromb. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamainternmed.2020.9241","article-title":"Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19","volume":"181","author":"Jering","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zahid, S., Mohamed, M.S., Wassif, H., Nazir, N.T., Khan, S.S., and Michos, E.D. (2022). Analysis of cardiovascular complications during delivery admissions among patients with systemic lupus erythematosus, 2004\u20132019. JAMA Netw. Open, 5.","DOI":"10.1001\/jamanetworkopen.2022.43388"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/AOG.0000000000004339","article-title":"Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19)","volume":"137","author":"Metz","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00277-020-04305-x","article-title":"Characteristics of coagulation alteration in patients with COVID-19","volume":"100","author":"Luo","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Cu\u00f1arro-L\u00f3pez, Y., Pintado-Recarte, P., Cueto-Hern\u00e1ndez, I., Hern\u00e1ndez-Mart\u00edn, C., Pay\u00e1-Mart\u00ednez, M.P., Mu\u00f1\u00f3z-Ch\u00e1puli, M.d.M., Cano-Valderrama, \u00d3., Bravo, C., Bujan, J., and \u00c1lvarez-Mon, M. (2021). The profile of the obstetric patients with SARS-CoV-2 infection according to country of origin of the publication: A systematic review of the literature. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020360"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.redar.2020.06.009","article-title":"Practical Recommendations in the Obstetrical Patient with a COVID-19 Infection","volume":"67","author":"Guasch","year":"2020","journal-title":"Rev. Esp. Anestesiol. Reanim."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s Choice\u2013European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijcard.2020.12.024","article-title":"Reduction in All-Cause Mortality in COVID-19 Patients on Chronic Oral Anticoagulation: A Population-Based Propensity Score Matched Study","volume":"329","author":"Denas","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant Treatment Is Associated with Decreased Mortality in Severe Coronavirus Disease 2019 Patients with Coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sholzberg, M., Tang, G.H., Negri, E., Rahhal, H., Kreuziger, L.B., Pompilio, C.E., James, P., Fralick, M., AlHamzah, M., and Alomran, F. (2021). Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG\u2013RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials, 22.","DOI":"10.1186\/s13063-021-05076-0"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood.2020006941","article-title":"Impact of Anticoagulation Prior to COVID-19 Infection: A Propensity Score-Matched Cohort Study","volume":"136","author":"Tremblay","year":"2020","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/jocs.14707","article-title":"Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about?","volume":"35","author":"Omidi","year":"2020","journal-title":"J. Card. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/1471-0528.13491","article-title":"Prosthetic heart valves in pregnancy, outcomes for women and their babies: A systematic review and meta-analysis","volume":"122","author":"Lawley","year":"2015","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.arbres.2020.11.016","article-title":"Impact of COVID-19 on Tuberculosis Control","volume":"57","year":"2021","journal-title":"Arch. Bronconeumol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s44197-023-00085-5","article-title":"Tuberculosis in the Russian Federation: Prognosis and Epidemiological models Situation after the COVID-19 Pandemic","volume":"13","author":"Starshinova","year":"2023","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2350\/11-05-1039-CC.1","article-title":"Mycobacterium tuberculosis Infection of the placenta: A study of the early (innate) inflammatory response in two cases","volume":"15","author":"Abramowsky","year":"2012","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Varlas, V.N., Bor\u0219, R.G., Plotogea, M., Iordache, M., Mehedin\u021bu, C., and C\u00eerstoiu, M.M. (2023). Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20031949"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Dennis, E.M., Hao, Y., Tamambang, M., Roshan, T.N., Gatlin, K.J., Bghigh, H., Ogunyemi, O.T., Diallo, F., Spooner, K.K., and Salemi, J.L. (2018). Tuberculosis during pregnancy in the United States: Racial\/ethnic disparities in pregnancy complications and in-hospital death. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194836"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Wu, D., Li, X., Wan, H., Shami, A., Alhassan, H.H., Al-Enazi, M.M., Mir Najib Ullah, S.N., Nashwan, A.J., and Khan, S. (2023). Analysis of prevalence of adverse events connected with anti-tuberculosis drugs during pregnancy: A meta-analysis. Heliyon, 9.","DOI":"10.1016\/j.heliyon.2023.e22786"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.7196\/SAMJ.2021.v111i12.15822","article-title":"Effect of COVID-19 on HI.V.; tuberculosis, and prevention of mother-to-child transmission of HIV indicators in Mopani district, South Africa","volume":"111","author":"Mutyambizi","year":"2021","journal-title":"S. Afr. Med. J."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Malham\u00e9, I., Cormier, M., Sugarman, J., and Schwartzman, K. (2016). Latent Tuberculosis in Pregnancy: A Systematic Review. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154825"},{"key":"ref_77","unstructured":"World Health Organization (2022). WHO Consolidated Guidelines on Tuberculosis. Module 3: Diagnosis. Tests for Tuberculosis Infection, World Health Organization."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/ijmy.ijmy_131_20","article-title":"Recombinant tuberculosis allergen (Diaskintest\u00ae) in tuberculosis diagnostic in Russia (meta-analysis)","volume":"9","author":"Starshinova","year":"2020","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Slogotskaya, L., Bogorodskaya, E., Ivanova, D., and Sevostyanova, T. (2018). Sevostyanova Comparative sensitivity of the test with tuberculosis recombinant allergen, containing ESAT6-CFP10 protein, and Mantoux test with 2 TU PPD-L in newly diagnosed tuberculosis children and adolescents in Moscow. PLoS ONE, 13.","DOI":"10.1101\/343665"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1183\/13993003.01464-2015","article-title":"Sensitivity of C-Tb: A novel RD-1-specific skin test for the diagnosis of tuberculosis infection","volume":"47","author":"Hoff","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/cid\/ciad030","article-title":"Assessing the Diagnostic Performance of New Commercial Interferon-\u03b3 Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-Analysis","volume":"76","author":"Apriani","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Lu, X., Li, C., Li, W., Long, X., Fang, Y., Sun, R., Jin, F., Fu, E., and Xie, Y. (2019). Use of Interferon-\u03b3 release assay for the diagnosis of female genital tuberculosis in Northwest China. J. Clin. Lab. Anal., 33.","DOI":"10.1002\/jcla.22621"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/INF.0b013e3181a16394","article-title":"The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status","volume":"28","author":"Haustein","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2020.05.045","article-title":"Genital tuberculosis screening at an academic fertility center in the United States","volume":"223","author":"Tal","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/AOG.0b013e31823834a9","article-title":"Interferon gamma release assay compared with the tuberculin skin test for latent tuberculosis detection in pregnancy","volume":"118","author":"Worjoloh","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lighter-Fisher, J. (2012). Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy. Obstet. Gynecol., 120.","DOI":"10.1097\/AOG.0b013e3182617fe8"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"24","DOI":"10.17161\/kjm.v3i2.11311","article-title":"Use of the QuantiFERON\u00ae-TB Gold Assay in Pregnant Patients","volume":"3","author":"Chehab","year":"2010","journal-title":"Kans. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Mathad, J.S., Bhosale, R., Sangar, V., Mave, V., Gupte, N., Kanade, S., Nangude, A., Chopade, K., Suryavanshi, N., and Deshpande, P. (2014). Pregnancy differentially impacts performance of latent tuberculosis diagnostics in a high-burden setting. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092308"},{"key":"ref_90","first-page":"28","article-title":"New skin test for the diagnosis of tuberculosis based on recombinant protein ESAT-CFP","volume":"4","author":"Kiselev","year":"2008","journal-title":"Like Honey"},{"key":"ref_91","first-page":"11","article-title":"Clinical studies of the new skin test \u201cDIASKINTEST\u00ae\u201d for the diagnosis of tuberculosis","volume":"2","author":"Kiselev","year":"2009","journal-title":"Probl. Tube. Lung Dis."},{"key":"ref_92","first-page":"24","article-title":"Experience of using skin test with recombinant tuberculosis allergen in pregnant women","volume":"4","author":"Borisova","year":"2017","journal-title":"Tuberc. Soc. Signif. Dis."},{"key":"ref_93","unstructured":"Centers for Disease Control and Prevention (2020, February 13). Latent Tuberculosis Treatment Guidelines: 2020 Update, Available online: https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/rr\/rr6901a1.htm."},{"key":"ref_94","unstructured":"WHO (2014). Guidelines for the Management of Latent Tuberculosis Infection, WHO. Available online: http:\/\/apps.who.int\/medicinedocs\/documents\/s21682ru\/s21682ru.pdf."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/infdis\/jis009","article-title":"Prevention, diagnosis, and treatment of tuberculosis in children and mothers: Evidence for action for maternal, neonatal, and child health services","volume":"205","author":"Getahun","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_96","unstructured":"(2021, November 05). Management of Tuberculosis in Pregnant Women and Newborn Infants\u2014Guideline, Version 3.2, Available online: https:\/\/www.health.qld.gov.au\/__data\/assets\/pdf_file\/0030\/444558\/tb-guideline-pregnancy.pdf."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/dmd.31.4.421","article-title":"Parkinson A: Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes","volume":"31","author":"Madan","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.1993.125","article-title":"Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans","volume":"54","author":"Zand","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0009-9236(98)90147-3","article-title":"Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress","volume":"64","author":"Leclercq","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Riccardi, N., Canetti, D., Rodari, P., Besozzi, G., Saderi, L., Dettori, M., Codecasa, L.R., and Sotgiu, G. (2020). Tuberculosis and pharmacological interactions: A narrative review. Curr. Res. Pharmacol. Drug Discov., 15.","DOI":"10.1016\/j.crphar.2020.100007"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00000441-199905000-00007","article-title":"Isoniazid drug and food interactions","volume":"317","author":"Self","year":"1999","journal-title":"Am. J. Med. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40262-019-00764-2","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis","volume":"58","author":"Abulfathi","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.0306-5251.2001.01545.x","article-title":"The effects of rifampicin on the pharmacokinetics and pharmacodynamics of orally administered nilvadipine to healthy subjects","volume":"53","author":"Saima","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/fcp.12292","article-title":"Rifampicin reverses nicardipine effect inducing uncontrolled essential hypertension","volume":"31","author":"Cordeanu","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","article-title":"Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: An open-label, randomised controlled trial","volume":"394","author":"Easterling","year":"2019","journal-title":"Lancet"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/echo.13884","article-title":"Safety of nifedipine in threatened preterm labor: Investigation by three-dimensional echocardiography","volume":"35","author":"Grin","year":"2018","journal-title":"Echocardiography"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dkn330","article-title":"Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs","volume":"62","author":"Sousa","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2012.747952","article-title":"Update on rifampin, rifabutin, and rifapentine drug interactions","volume":"29","author":"Baciewicz","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.2024.10704","article-title":"Acetaminophen Use During Pregnancy","volume":"332","author":"Cramer","year":"2024","journal-title":"J. Am. Med. Assoc."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.toxlet.2014.06.006","article-title":"Inhibition of cytochrome P450 by ethambutol in human liver microsomes","volume":"229","author":"Lee","year":"2014","journal-title":"Toxicol. Lett."},{"key":"ref_111","first-page":"61","article-title":"Renal and hepatic interactions of acetaminophen and amikacin in the infant rat","volume":"41","year":"1998","journal-title":"Proc. West Pharmacol. Soc."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Strydom, N., Gupta, S.V., Fox, W.S., Via, L.E., Bang, H., Lee, M., Eum, S., Shim, T., Barry, C.E., and Zimmerman, M. (2019). Tuberculosis drugs\u2019 distribution and emergence of resistance in patient\u2019s lung lesions: A mechanistic model and tool for regimen and dose optimization. PLoS Med., 16.","DOI":"10.1371\/journal.pmed.1002773"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"S308","DOI":"10.1093\/cid\/ciy624","article-title":"d-Cycloserine Pharmacokinetics\/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal","volume":"67","author":"Deshpande","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Li, Y., Lei, G., Dong, W., Lan, T., Fan, J., and Qin, S. (2024). Differential distribution of linezolid in diseased and nondiseased bones in patients with spinal tuberculosis. BMC Infect Dis., 24.","DOI":"10.1186\/s12879-023-08970-x"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcrc.2020.12.005","article-title":"Interactions between carbapenems and valproic acid among the patients in the intensive care units","volume":"62","author":"Chen","year":"2021","journal-title":"J. Crit. Care"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","article-title":"Interaction between valproic acid and carbapenem antibiotics","volume":"39","author":"Mori","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/1381612825666190320162507","article-title":"Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV","volume":"25","author":"Hodel","year":"2019","journal-title":"Curr Pharm Des."},{"key":"ref_118","unstructured":"WHO (2013). The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance, WHO."},{"key":"ref_119","first-page":"41","article-title":"Development and introduction into clinical practice of a new pharmacological substance from the class of diarylquinolines","volume":"84","author":"Kudlay","year":"2021","journal-title":"Exp. Clin. Pharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Stadler, J.A.M., Maartens, G., Meintjes, G., and Wasserman, S. (2023). Clofazimine for the treatment of tuberculosis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1100488"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"de Castro, R.R., Carmo, F.A.D., Martins, C., Simon, A., de Sousa, V.P., Rodrigues, C.R., Cabral, L.M., and Sarmento, B. (2021). Clofazimine functionalized polymeric nanoparticles for brain delivery in the tuberculosis treatment. Int. J. Pharm., 602.","DOI":"10.1016\/j.ijpharm.2021.120655"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"58","DOI":"10.21292\/2075-1230-2021-99-2-58-66","article-title":"Delamanid\u2014A new anti-tuberculosis drug: Application, limitations, prospects","volume":"99","author":"Zimina","year":"2021","journal-title":"Tuberc. Lung Dis."},{"key":"ref_123","first-page":"779","article-title":"The role of delamanid in the treatment of drug-resistant tuberculosis","volume":"11","author":"Lewis","year":"2015","journal-title":"Ther. Clin. Risk. Manag."},{"key":"ref_124","first-page":"87","article-title":"Delamanid, a new 6-nitro-2, 3-23 dihydroimidazo [2, 1-b] oxazole for the management of tuberculosis resistant to at least isoniazid 24 and rifampicin","volume":"2","author":"Diacon","year":"2014","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Karonova, T.L., Mikhaylova, A.A., Golovatyuk, K.A., Chernikova, A.T., Korobova, Z.R., Liubimova, N.E., Starshinova, A.A., Kudlay, D.A., Totolian, A.A., and Shlyakhto, E.V. (2024). Vitamin D Metabolism Parameters and Cytokine Profile in COVID-19 Patients with Bolus Cholecalciferol Supplementation. Diagnostics, 14.","DOI":"10.3390\/diagnostics14131408"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1016\/j.vaccine.2023.03.038","article-title":"Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis","volume":"41","author":"Ciapponi","year":"2023","journal-title":"Vaccine"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18565\/aig.2022.5.53-58","article-title":"Monitoring of COVID-19 vaccination in pregnant women of Siberia and the Russian Far East","volume":"5","author":"Artymuk","year":"2022","journal-title":"Akusherstvo I Ginekol.\/Obstet. Gynecol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pathophysiology31020020","article-title":"Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations","volume":"31","author":"Starshinova","year":"2024","journal-title":"Pathophysiology"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Sefiyeva, G., Shadrina, U., Vavilova, T., Sirotkina, O., Bautin, A., Chynybekova, A., Pozhidaeva, A., Stepanovykh, E., Starshinova, A., and Kudlay, D. (2024). Pregnant Woman in Outcomes with Prosthetic Heart Valves. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11110353"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Vasichkina, E., Alekseeva, D., Karev, V., Podyacheva, E., Kudryavtsev, I., Glushkova, A., Starshinova, A.Y., Kudlay, D., and Starshinova, A. (2023). Cardiac Involvement in Children Affected by COVID-19: Clinical Features and Diagnosis. Diagnostics, 13.","DOI":"10.3390\/diagnostics13010120"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Mitrofanova, L., Makarov, I., Goncharova, E., Makarova, T., Starshinova, A., Kudlay, D., and Shlaykhto, E. (2023). High Risk of Heart Tumors after COVID-19. Life, 13.","DOI":"10.3390\/life13102087"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Semnani, K., and Esmaeili, S. (2025). Nuances in the global impact of COVID-19 on tuberculosis control efforts: An updated review. Medicine, 104.","DOI":"10.1097\/MD.0000000000042195"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Dlangalala, T., Musekiwa, A., and Mashamba-Thompson, T. (2023). Impact of COVID-19 on TB diagnostic services at primary healthcare clinics in eThekwini district, South Africa. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-43589-7"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Geng, Y., Li, G., and Zhang, L. (2021). The Impact of COVID-19 interventions on influenza and mycobacterium tuberculosis infection. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.672568"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5681\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:24:55Z","timestamp":1760034295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":134,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165681"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165681","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}